Author Oettle, H.

1 to 3 of 3 Items
  • 2019 Journal Article | 
    ​ ​Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial​
    Wittel, U. A.; Lubgan, D.; Ghadimi, M. ; Belyaev, O.; Uhl, W.; Bechstein, W. O. & Grützmann, R. et al.​ (2019) 
    BMC Cancer19(1).​ DOI: https://doi.org/10.1186/s12885-019-6148-5 
    Details  DOI 
  • 2020 Journal Article
    ​ ​CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results​
    Sinn, M.; Liersch, T. ; Riess, H.; Gellert, K.; Stübs, P.; Waldschmidt, D. & Lammert, F. et al.​ (2020) 
    European Journal of Cancer138 pp. 172​-181​.​ DOI: https://doi.org/10.1016/j.ejca.2020.06.032 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial​
    Fietkau, R.; Grützmann, R.; Wittel, U. A.; Croner, R. S.; Jacobasch, L.; Neumann, U. P. & Reinacher-Schick, A. et al.​ (2020) 
    Strahlentherapie und Onkologie197(1) pp. 8​-18​.​ DOI: https://doi.org/10.1007/s00066-020-01680-2 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page